Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?
D000818:Animals; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003422:Critical Care / Q000379:methods; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D016328:NF-kappa B / Q000187:drug effects / Q000378:metabolism*; D011379:Prognosis; D051381:Rats; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy*; D012717:Sesquiterpenes / Q000494:pharmacology*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D016328:NF-kappa B; D012717:Sesquiterpenes; C002669:parthenolide